KRAS and colorectal carcinoma: Various investigators have identified that, relative to healthy peoples or non-metastatic patients, five exosomal proteins (exosomal HSPC111, ADAM17, KRAS, Wnt5a, and IntegrinB5) are significantly overexpressed in patients afflicted with highly metastatic CRC and GC [68–73].